Works matching IS 09024441 AND DT 2015 AND VI 95 AND IP 6


Results: 15
    1
    2
    3
    4
    5
    6
    7

    A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria.

    Published in:
    European Journal of Haematology, 2015, v. 95, n. 6, p. 558, doi. 10.1111/ejh.12536
    By:
    • Murai, Kazunori;
    • Akagi, Tomoaki;
    • Shimosegawa, Kenji;
    • Sugawara, Tomohiro;
    • Ishizawa, Kenichi;
    • Ito, Shigeki;
    • Murai, Keiko;
    • Motegi, Mutsuhito;
    • Yokoyama, Hisayuki;
    • Noji, Hideyoshi;
    • Tajima, Katsushi;
    • Kimura, Jun;
    • Chou, Takaaki;
    • Ogawa, Kazuei;
    • Harigae, Hideo;
    • Kubo, Kohmei;
    • Oba, Koji;
    • Sakamoto, Junichi;
    • Ishida, Yoji
    Publication type:
    Article
    8
    9
    10

    The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.

    Published in:
    European Journal of Haematology, 2015, v. 95, n. 6, p. 538, doi. 10.1111/ejh.12529
    By:
    • Troppan, Katharina T.;
    • Melchardt, Thomas;
    • Deutsch, Alexander;
    • Schlick, Konstantin;
    • Stojakovic, Tatjana;
    • Bullock, Marc D.;
    • Reitz, Daniel;
    • Beham‐Schmid, Christine;
    • Weiss, Lukas;
    • Neureiter, Daniel;
    • Wenzl, Kerstin;
    • Greil, Richard;
    • Neumeister, Peter;
    • Egle, Alexander;
    • Pichler, Martin
    Publication type:
    Article
    11
    12
    13
    14
    15